Hallym Univ. Medical Center
Welcome,         Profile    Billing    Logout  
 7 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kim, Hyo Jeong
NCT05245604: Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients

Recruiting
3
182
RoW
TJO-087, Cyclosporine ophthalmic solution 0.05%
Taejoon Pharmaceutical Co., Ltd.
Dry Eye Syndrome
08/22
04/23
RSV OA=ADJ=012, NCT06534892: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Recruiting
3
12000
Europe, Canada, Japan, US, RoW
RSVPreF3 OA vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
09/26
09/26
VIVID-2, NCT04232553 / 2019-002687-27: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Recruiting
3
778
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Crohn's Disease
11/24
12/26
NCT03814759: Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

Completed
2
102
RoW
TS-1 + cisplatin, radiation
Yonsei University
Gastric Adenocarcinoma
12/21
07/22
NCT03798106: A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma

Completed
2
46
RoW
Durvalumab, pazopanib
Yonsei University
Sarcoma
08/22
08/22
ALBATROSS, NCT04605770: Pemetrexed, Cisplatin With Soft Tissue Sarcoma

Recruiting
2
164
RoW
pemetrexed+cisplatin
Yonsei University
Sarcoma,Soft Tissue
11/27
11/27
NCT05224999: Nivolumab for Recurrent/Metastatic Carcinosarcoma

Recruiting
2
28
RoW
nivolumab
Yonsei University
Recurrent/Metastatic Carcinosarcoma
01/23
12/23
NCT03671850: VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

Recruiting
2
48
RoW
VT-EBV-N, Placebo
ViGenCell Inc.
Extranodal NK/T-cell Lymphoma
12/23
06/24
NCT03789617: A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Recruiting
1/2
72
RoW
EBViNT Cell, Eutil autologous blood-derived T lymphocytes
Eutilex
EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
09/22
12/24
NCT03802084: A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor

Completed
1/2
24
RoW
vactosertib/imatinib combination
Hyo Song Kim
Desmoid Tumor
03/24
03/24
AD1208, NCT06911333: in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

Recruiting
1/2
36
RoW
AD1208
Avelos Therapeutics Inc.
Solid Tumor, Adult, Tumor, Solid, Solid Tumor, Solid Tumor, Unspecified, Adult, Solid Tumor Cancer, Solid Tumors Refractory to Standard Therapy, Solid Tumor in Advanced Stage
06/29
02/30
VISION, NCT04151615: VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Completed
N/A
203
RoW
Boryung Pharmaceutical Co., Ltd
Multiple Myeloma
01/23
01/23
NCT04333342: Heart Rate Monitoring by Wearable Devices in Graves' Disease

Active, not recruiting
N/A
180
RoW
heart rate monitoring using wearable devices
Seoul National University Bundang Hospital
Graves' Disease in Remission (Disorder)
09/23
12/23
rarecancer, NCT06746766: Registry Study on Rare Cancers in Korea

Recruiting
N/A
500
RoW
Yonsei University
Rare Cancer
12/27
12/27
NCT06872801: Home High-Flow Nasal Cannula Vs. Noninvasive Ventilation for Stable Chronic Respiratory Failure

Not yet recruiting
N/A
38
RoW
High-Flow Nasal Cannula, Noninvasive Ventilation
Wonju Severance Christian Hospital
Stable Chronic Hypercapnic Respiratory Failure
03/26
06/26
Choi, Jeong hee
NCT05544942: GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health

Recruiting
N/A
120
RoW
Lactobacillus plantarum, maltodextrin
Green Cross Wellbeing
Respiratory Symptoms
03/23
05/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kim, Hyo Jeong
NCT05245604: Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients

Recruiting
3
182
RoW
TJO-087, Cyclosporine ophthalmic solution 0.05%
Taejoon Pharmaceutical Co., Ltd.
Dry Eye Syndrome
08/22
04/23
RSV OA=ADJ=012, NCT06534892: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Recruiting
3
12000
Europe, Canada, Japan, US, RoW
RSVPreF3 OA vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
09/26
09/26
VIVID-2, NCT04232553 / 2019-002687-27: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Recruiting
3
778
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Crohn's Disease
11/24
12/26
NCT03814759: Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

Completed
2
102
RoW
TS-1 + cisplatin, radiation
Yonsei University
Gastric Adenocarcinoma
12/21
07/22
NCT03798106: A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma

Completed
2
46
RoW
Durvalumab, pazopanib
Yonsei University
Sarcoma
08/22
08/22
ALBATROSS, NCT04605770: Pemetrexed, Cisplatin With Soft Tissue Sarcoma

Recruiting
2
164
RoW
pemetrexed+cisplatin
Yonsei University
Sarcoma,Soft Tissue
11/27
11/27
NCT05224999: Nivolumab for Recurrent/Metastatic Carcinosarcoma

Recruiting
2
28
RoW
nivolumab
Yonsei University
Recurrent/Metastatic Carcinosarcoma
01/23
12/23
NCT03671850: VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

Recruiting
2
48
RoW
VT-EBV-N, Placebo
ViGenCell Inc.
Extranodal NK/T-cell Lymphoma
12/23
06/24
NCT03789617: A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Recruiting
1/2
72
RoW
EBViNT Cell, Eutil autologous blood-derived T lymphocytes
Eutilex
EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
09/22
12/24
NCT03802084: A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor

Completed
1/2
24
RoW
vactosertib/imatinib combination
Hyo Song Kim
Desmoid Tumor
03/24
03/24
AD1208, NCT06911333: in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

Recruiting
1/2
36
RoW
AD1208
Avelos Therapeutics Inc.
Solid Tumor, Adult, Tumor, Solid, Solid Tumor, Solid Tumor, Unspecified, Adult, Solid Tumor Cancer, Solid Tumors Refractory to Standard Therapy, Solid Tumor in Advanced Stage
06/29
02/30
VISION, NCT04151615: VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Completed
N/A
203
RoW
Boryung Pharmaceutical Co., Ltd
Multiple Myeloma
01/23
01/23
NCT04333342: Heart Rate Monitoring by Wearable Devices in Graves' Disease

Active, not recruiting
N/A
180
RoW
heart rate monitoring using wearable devices
Seoul National University Bundang Hospital
Graves' Disease in Remission (Disorder)
09/23
12/23
rarecancer, NCT06746766: Registry Study on Rare Cancers in Korea

Recruiting
N/A
500
RoW
Yonsei University
Rare Cancer
12/27
12/27
NCT06872801: Home High-Flow Nasal Cannula Vs. Noninvasive Ventilation for Stable Chronic Respiratory Failure

Not yet recruiting
N/A
38
RoW
High-Flow Nasal Cannula, Noninvasive Ventilation
Wonju Severance Christian Hospital
Stable Chronic Hypercapnic Respiratory Failure
03/26
06/26
Choi, Jeong hee
NCT05544942: GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health

Recruiting
N/A
120
RoW
Lactobacillus plantarum, maltodextrin
Green Cross Wellbeing
Respiratory Symptoms
03/23
05/23

Download Options